Table 2. Immune cells according to clinical parameters of multiple myeloma patients.
|
Immunoglobulin heavy chain type
|
Light chain type
|
|||||
|---|---|---|---|---|---|---|
| Immune cell sub-population | Stage 2 Durie–Salmon | Stage 3 Durie–Salmon | IgA | IgG | Kappa | Lambda |
| PDC (%) | ||||||
| Median | 0.02 | 0.04 | 0.02 | 0.15 | 0.03 | 0.04 |
| Range | 0.01–0.89 | 0.01–1.23 | 0.01–0.04 | 0.02–0.58 | 0.01–1.23 | 0.01–0.89 |
| MDC (%) | ||||||
| Median | 0.15 | 0.16 | 0.14 | 0.15 | 0.16 | 0.16 |
| Range | 0.04–0.58 | 0.01–0.69 | 0.01–0.69 | 0.02–0.58 | 0.01–0.69 | 0.03–0.40 |
| Treg (%) | ||||||
| Median | 6.29 | 6.16 | 5.88 | 5.83 | 5.88 | 6.19 |
| Range | 1.88–14.86 | 0.45–57.84 | 1.79–10.34 | 0.45–20.57 | 0.45–47.88 | 1.79–14.70 |
Abbreviations: Ig=immunoglobulin; MDC=myeloid dendritic cell; PDC=plasmacytoid dendritic cell; Treg=T regulatory cell.